Publications:

Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL.

Cancers

Hare, Lucy L; Burke, G A Amos GAA; Turner, Suzanne D SD

Publication Date: 2021-11-29

Variant appearance in text: ALK: I1268L

PubMed Link: 34885113

Variant Present in the following documents:

• Main text
• cancers-13-06003.pdf

View BVdb publication page

Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL.

Cancers

Hare, Lucy L; Burke, G A Amos GAA; Turner, Suzanne D SD

Publication Date: 2021-11-29

Variant appearance in text: ALK: I1268L

PubMed Link: 34885113

Variant Present in the following documents:

• Main text
• cancers-13-06003.pdf

View BVdb publication page

[Advances in Drug Resistance Mechanisms and Prognostic Markers of Targeted Therapy in ALK-positive Non-small Cell Lung Cancer].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer

Wang, Shasha S; Shi, Yuankai Y; Han, Xiaohong X

Publication Date: 2020-11-20

Variant appearance in text: ALK: I1268L

PubMed Link: 33203201

Variant Present in the following documents:

• Main text
• zgfazz-23-11-1014.pdf

View BVdb publication page

Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance.

Ebiomedicine

Okada, Koutaroh K; Araki, Mitsugu M; Sakashita, Takuya T; Ma, Biao B; Kanada, Ryo R; Yanagitani, Noriko N; Horiike, Atsushi A; Koike, Sumie S; Oh-Hara, Tomoko T; Watanabe, Kana K; Tamai, Keiichi K; Maemondo, Makoto M; Nishio, Makoto M; Ishikawa, Takeshi T; Okuno, Yasushi Y; Fujita, Naoya N; Katayama, Ryohei R

Publication Date: 2019-03

Variant appearance in text: ALK: I1268L

PubMed Link: 30662002

Variant Present in the following documents:

• Main text
• main.pdf
• mmc1.pdf

View BVdb publication page